Paraoxonase-1 and ischemia-modified albumin in patients with end-stage renal disease

ISSN： 1138-7548

Source： Journal of Physiology and Biochemistry, Vol.67, Iss.3, 2011-09, pp. : 437-441

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Beneficial effects of an intradialytic cycling training program in patients with end-stage kidney disease

By Groussard Carole Rouchon-Isnard Myriam Coutard Céline Romain Fanny Malardé Ludivine Lemoine-Morel Sophie Martin Brice Pereira Bruno Boisseau Nathalie

Applied Physiology, Nutrition, and Metabolism, Vol. 40, Iss. 6, 2015-01 ,pp. : 550-556

NRC Research Press

Access to resources Recommend Favorite

High risk of renal dysfunction in patients with fulminant type 1 diabetes

Journal Of Diabetes Investigation, Vol. 9, Iss. 1, 2018-01 ,pp. : 146-151

John Wiley & Sons Inc

Access to resources Recommend Favorite

Time-dependent modulation of rat serum paraoxonase 1 activity by fasting

By Thomàs-Moyà Elena Nadal-Casellas Antònia Gianotti Magdalena Lladó Isabel Proenza Ana

Pflügers Archiv, Vol. 453, Iss. 6, 2007-03 ,pp. : 831-837

Springer Publishing Company

Access to resources Recommend Favorite

Podocyte NF‐κB is dispensable for the pathogenesis of renal ischemia‐reperfusion injury

Physiological Reports, Vol. 4, Iss. 16, 2016-08 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

The anorexic hormone Peptide YY3–36 is rapidly metabolized to inactive Peptide YY3–34 in vivo

Physiological Reports, Vol. 3, Iss. 7, 2015-07 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite